These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7519627)

  • 1. The mycoplasma-related inhibitor of HIV-1 reverse transcriptase has a DNase activity and is present in the particle-free supernatants of contaminated cultures.
    el-Farrash MA; Kannagi M; Kuroda MJ; Yoshida T; Harada S
    J Virol Methods; 1994 Apr; 47(1-2):73-82. PubMed ID: 7519627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of HIV-1 reverse transcriptase activity by culture supernatants of mycoplasmas.
    Shang H; Miyakawa Y; Sasaki T; Nakashima H; Ito M
    Microbiol Immunol; 1995; 39(12):987-93. PubMed ID: 8789058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV type 1 reverse transcriptase assay by nucleases produced by contaminating mycoplasmas.
    Quillent C; Grau O; Clavel F; Montagnier L; Blanchard A
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1251-7. PubMed ID: 7531461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HIV-1 reverse transcriptase activity by mycoplasma contamination of cell cultures.
    Vasudevachari MB; Mast TC; Salzman NP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):411-6. PubMed ID: 1692726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monocyte-derived factor interferes with detection of reverse transcriptase in HIV-1 infection.
    Recker DP; Kulaga H; Dorsett D; Folks T; Kindt TJ
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):73-81. PubMed ID: 1707643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
    Ben-Artzi H; Zeelon E; Gorecki M; Panet A
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
    Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
    Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorimetric reverse transcriptase assay for HIV-1.
    Suzuki K; Craddock BP; Kano T; Steigbigel RT
    J Virol Methods; 1993 Jan; 41(1):21-8. PubMed ID: 7679395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The inhibitory effects of catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and DNA polymerases].
    Tao P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Oct; 14(5):334-8. PubMed ID: 1284389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
    Loya S; Rudi A; Kashman Y; Hizi A
    Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.
    Lo SC; Tsai S; Benish JR; Shih JW; Wear DJ; Wong DM
    Science; 1991 Mar; 251(4997):1074-6. PubMed ID: 1705362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.
    Althaus IW; Chou KC; Lemay RJ; Franks KM; Deibel MR; Kezdy FJ; Resnick L; Busso ME; So AG; Downey KM; Romero DL; Thomas RC; Aristoff PA; Tarpley WG; Reusser F
    Biochem Pharmacol; 1996 Mar; 51(6):743-50. PubMed ID: 8602869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors.
    Balzarini J; Weeger M; Camarasa MJ; De Clercq E; Uberla K
    Biochem Biophys Res Commun; 1995 Jun; 211(3):850-6. PubMed ID: 7541200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
    Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.
    Martin JL; Wilson JE; Haynes RL; Furman PA
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6135-9. PubMed ID: 7687061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.